Home›Research›Compare›Davunetide vs Desmopressin
Peptide Comparison
Davunetide vs Desmopressin
Both are Cognitive peptides.
Desmopressin
DDAVP
Half-life: 1.5-2.5 hours (intranasal)
2 providers listed
Quick Verdict
Davunetide
Risk
Half-life
—
Desmopressin
Risk
Half-life
1.5-2.5 hours (intranasal)
Side-by-Side Comparison
About Davunetide
Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.
An 8-amino acid neuroprotective peptide derived from Activity-Dependent Neuroprotective Protein (ADNP). Among the most potent neuroprotective agents identified in preclinical models. Studied for Alzheimer's disease, schizophrenia, and traumatic brain injury.
Research Areas
About Desmopressin
Synthetic vasopressin analogue (V2R selective); crosses blood-brain barrier; enhances hippocampal LTP and memory consolidation; longer-acting than natural vasopressin
A synthetic vasopressin analogue with preferential V2R activity. Used medically for diabetes insipidus; studied off-label for memory enhancement and cognitive improvement.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Davunetide
Browse directory →
Providers offering
Desmopressin
2 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More cognitive Comparisons
Browse all peptides →Educational research tools — not medical advice.